Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

We are currently facing an issue in receiving the NSE feed. Hence the stock prices are not updated. We are working on fixing this at the earliest. We regret the inconvenience caused.

VADIVARHE SPECIALITY CHEMICALS 2021-22 Annual Report Analysis
Mon, 7 Nov

VADIVARHE SPECIALITY CHEMICALS has announced its results for the year ended March 2022. Let us have a look at the detailed performance review of the company during FY21-22.

VADIVARHE SPECIALITY CHEMICALS Income Statement Analysis

  • Operating income during the year fell 19.0% on a year-on-year (YoY) basis.
  • The company's operating profit was by NA YoY during the fiscal. Operating profit margins witnessed a growth and stood at 31.1% in FY22 as against 0.5% in FY21.
  • Depreciation charges decreased by 0.9% and finance costs increased by 28.6% YoY, respectively.
  • Other income grew by 37.9% YoY.
  • Net profit for the year grew by NA YoY.
  • Net profit margins during the year declined from 10.4% in FY21 to 44.8% in FY22.

VADIVARHE SPECIALITY CHEMICALS Income Statement 2021-22

No. of Mths Year Ending 12 Mar-21* 12 Mar-22* % Change
Net Sales Rs m 265 214 -19.0%
Other income Rs m 4 5 37.9%
Total Revenues Rs m 269 220 -18.1%
Gross profit Rs m 1 -67 NA
Depreciation Rs m 18 18 -0.9%
Interest Rs m 13 17 28.6%
Profit before tax Rs m -26 -96 NA
Tax Rs m 2 0 -100.0%
Profit after tax Rs m -28 -96 NA
Gross profit margin % 0.5 -31.1
Effective tax rate % -6.6 0.0
Net profit margin % -10.4 -44.8
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



RESPONSE PENDING: Your Meeting with Tanushree Banerjee Tomorrow...

VADIVARHE SPECIALITY CHEMICALS Balance Sheet Analysis

  • The company's current liabilities during FY22 stood at Rs 198 million as compared to Rs 171 million in FY21, thereby witnessing an increase of 15.6%.
  • Long-term debt stood at Rs 159 million as compared to Rs 146 million during FY21, a growth of 9.3%.
  • Current assets fell 24% and stood at Rs 144 million, while fixed assets fell 3% and stood at Rs 273 million in FY22.
  • Overall, the total assets and liabilities for FY22 stood at Rs 417 million as against Rs 472 million during FY21, thereby witnessing a fall of 12%.

VADIVARHE SPECIALITY CHEMICALS Balance Sheet as on March 2022

No. of Mths Year Ending 12 Mar-21* 12 Mar-22* % Change
Networth Rs m 149 53 -64.5
 
Current Liabilities Rs m 171 198 15.6
Long-term Debt Rs m 146 159 9.3
Total Liabilities Rs m 472 417 -11.7
 
Current assets Rs m 190 144 -24.1
Fixed Assets Rs m 282 273 -3.3
Total Assets Rs m 472 417 -11.7
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



VADIVARHE SPECIALITY CHEMICALS Cash Flow Statement Analysis

  • VADIVARHE SPECIALITY CHEMICALS's cash flow from operating activities (CFO) during FY22 stood at Rs 17 million on a YoY basis.
  • Cash flow from investing activities (CFI) during FY22 stood at Rs -8 million on a YoY basis.
  • Cash flow from financial activities (CFF) during FY22 stood at Rs -10 million on a YoY basis.
  • Overall, net cash flows for the company during FY22 stood at Rs -2 million from the Rs 3 million net cash flows seen during FY21.

VADIVARHE SPECIALITY CHEMICALS Cash Flow Statement 2021-22

Particulars No. of months 12 12 % Change
Year Ending Mar-21 Mar-22
Cash Flow from Operating Activities Rs m -3 17 -
Cash Flow from Investing Activities Rs m 0 -8 -
Cash Flow from Financing Activities Rs m 6 -10 -
Net Cash Flow Rs m 3 -2 -
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Current Valuations for VADIVARHE SPECIALITY CHEMICALS

  • The trailing twelve-month earnings per share (EPS) of the company stands at Rs -7.5, an decline from the EPS of Rs -2.2 recorded last year.
  • The price to earnings (P/E) ratio, at the current price of Rs 27.6, stands at -5.5 times its trailing twelve months earnings.
  • The price to book value (P/BV) ratio at current price levels stands at 6.7 times, while the price to sales ratio stands at 1.6 times.
  • The company's price to cash flow (P/CF) ratio stood at -3.9 times its end-of-year operating cash flow earnings.

Per Share Data/Valuations

No. of Mths Year Ending 12 Mar-21* 12 Mar-22*
Sales per share (Unadj.) Rs 20.7 16.8
TTM Earnings per share Rs -2.2 -7.5
Diluted earnings per share Rs -2.2 -7.5
Price to Cash Flow x 0.0 -3.9
TTM P/E ratio x 0.0 -5.5
Price / Book Value ratio x 1.1 5.8
Market Cap Rs m 162 308
Dividends per share (Unadj.) Rs 0.0 0.0
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Ratio Analysis for VADIVARHE SPECIALITY CHEMICALS

  • Solvency Ratios
  • Current Ratio: The company's current ratio deteriorated and stood at 0.7x during FY22, from 1.1x during FY21. The current ratio measures the company's ability to pay short-term and long-term obligations.

    Interest Coverage Ratio: The company's interest coverage ratio deteriorated and stood at -4.7x during FY22, from -1.0x during FY21. The interest coverage ratio of a company states how easily a company can pay its interest expense on outstanding debt. A higher ratio is preferable.

  • Profitability Ratios
  • Return on Equity (ROE): The ROE for the company declined and down at -181.9% during FY22, from -18.5% during FY22. The ROE measures the ability of a firm to generate profits from its shareholders capital in the company.

    Return on Capital Employed (ROCE): The ROCE for the company declined and down at -37.4% during FY22, from -4.3% during FY21. The ROCE measures the ability of a firm to generate profits from its total capital (shareholder capital plus debt capital) employed in the company.

    Return on Assets (ROA): The ROA of the company declined and down at -19.0% during FY22, from -3.1% during FY21. The ROA measures how efficiently the company uses its assets to generate earnings.

Key Ratio Analysis

No. of Mths Year Ending 12 Mar-21* 12 Mar-22*
Current ratio x 1.1 0.7
Debtors’ Days Days 125,641,496 34,432,894
Interest coverage x -1.0 -4.7
Debt to equity ratio x 1.0 3.0
Return on assets % -3.1 -19.0
Return on equity % -18.5 -181.9
Return on capital employed % -4.3 -37.4
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



To see how VADIVARHE SPECIALITY CHEMICALS has performed over the last 5 years, please visit here.

VADIVARHE SPECIALITY CHEMICALS Share Price Performance

Over the last one year, VADIVARHE SPECIALITY CHEMICALS share price has moved down from Rs 0.0 to Rs 0.0, registering a loss of Rs 0.0 or around 0.0%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 24,020.7 (down 1.0%). Over the last one year it has moved down from 25,316.3 to 24,020.7, a loss of 1,296 points (down 5.1%).

Overall, the NIFTY 50 is up 0.5% over the year.

(To know more, check out historical annual results for VADIVARHE SPECIALITY CHEMICALS and quarterly results for VADIVARHE SPECIALITY CHEMICALS)

Annual Report FAQs

What is the current share price of VADIVARHE SPECIALITY CHEMICALS?

VADIVARHE SPECIALITY CHEMICALS currently trades at Rs 41.0 per share. You can check out the latest share price performance of VADIVARHE SPECIALITY CHEMICALS here...

What was the revenue of VADIVARHE SPECIALITY CHEMICALS in FY22? How does it compare to earlier years?

The revenues of VADIVARHE SPECIALITY CHEMICALS stood at Rs 220 m in FY22, which was down -18.1% compared to Rs 269 m reported in FY21.

VADIVARHE SPECIALITY CHEMICALS' revenue has fallen from Rs 256 m in FY18 to Rs 220 m in FY22.

Over the past 5 years, the revenue of VADIVARHE SPECIALITY CHEMICALS has grown at a CAGR of -3.7%.

What was the net profit of VADIVARHE SPECIALITY CHEMICALS in FY22? How does it compare to earlier years?

The net loss of VADIVARHE SPECIALITY CHEMICALS stood at Rs -96 m in FY22, which was NA compared to Rs -28 m reported in FY21.

This compares to a net loss of Rs -98 m in FY20 and a net profit of Rs 1 m in FY19.

Over the past 5 years, VADIVARHE SPECIALITY CHEMICALS net profit has grown at a CAGR of NaN%.

What does the cash flow statement of VADIVARHE SPECIALITY CHEMICALS reveal?

The cash flow statement is the financial statement that presents the cash inflows and outflows of a company during a given period of time.

This statement is one of the most useful tools for judging a company's liquidity position. The ratios and parameters in this statement helps test a company's financial health.

The cash flow statement of VADIVARHE SPECIALITY CHEMICALS reveals:

  • Cash flow from operations increased in FY22 and stood at Rs 17 m as compared to Rs -3 m in FY21.
  • Cash flow from investments decreased in FY22 and stood at Rs -8 m as compared to Rs 0 m in FY21.
  • Cash flow from financial activity decreased in FY22 and stood at Rs -10 m as compared to Rs 6 m in FY21.

Here's the cash flow statement of VADIVARHE SPECIALITY CHEMICALS for the past 5 years.

(Rs m)FY18FY19FY20FY21FY22
From Operations72-1241-317
From Investments-53-83-170-8
From Financial Activity-1193-236-10
Net Cashflow7-213-2

What does the Key Ratio analysis of VADIVARHE SPECIALITY CHEMICALS reveal?

Be it the company's profitability, operations effectiveness or utilization of funds, ratio analysis is an important tool which helps in making investment decisions.

The ratio/financial analysis of VADIVARHE SPECIALITY CHEMICALS reveals:

  • Operating profit margins witnessed a growth and stood at 31.1% in FY22 as against 0.5% in FY21.
  • Net profit margins declined from 10.4% in FY21 to 44.8% in FY22.
  • Debt to Equity ratio for FY22 stood at 3.0 as compared to 1.0 in FY21.

Here's the ratio/financial analysis of VADIVARHE SPECIALITY CHEMICALS for the past 5 years.

 FY18FY19FY20FY21FY22
Operating Profit Margin (%)15.27.2-30.20.5-31.1
Net Profit Margin (%)7.00.2-32.6-10.4-44.8
Debt to Equity Ratio (x)0.20.50.61.03.0

Equitymaster requests your view! Post a comment on "VADIVARHE SPECIALITY CHEMICALS 2021-22 Annual Report Analysis". Click here!